Fatal acquired coagulation factor V deficiency after hepatectomy for advanced hepatocellular carcinoma as a possible immune checkpoint inhibitor-related adverse event: a case report.

Shintaro ArakakiShinichiro OnoFutoshi KawamataShinichiro IshinoYasunori UesatoTomo NakajimaYukiko NishiSatoko MorishimaShingo ArakakiTatsuji MaeshiroMasayoshi SouriAkitada IchinoseHiroaki MasuzakiMitsuhisa Takatsuki

Published in: Surgical case reports (2023)

Severe acquired coagulopathy should be recognized as a possible life-threatening IrAE when using atezolizumab and bevacizumab for HCC.

Keyphrases

early onset
drug induced
metastatic colorectal cancer
liver metastases
replacement therapy
adverse drug